Hinge Health (HNGE) – Investment Analysts’ Recent Ratings Updates

Several brokerages have updated their recommendations and price targets on shares of Hinge Health (NYSE: HNGE) in the last few weeks:

• 9/30/2026 – Hinge Health had its price target raised by Needham & Company LLC from $97.00 to $115.00. They now have a “buy” rating on the stock.
• 9/29/2026 – Hinge Health is now covered by Bank of America Corporation. They set a “buy” rating and a $110.00 price target on the stock.
• 9/22/2026 – Hinge Health was upgraded by Weiss Ratings from “sell (d-)” to “hold (c)”.
• 9/22/2026 – Hinge Health had its price target raised by Robert W. Baird from $85.00 to $90.00. They now have a “neutral” rating on the stock.
• 9/8/2026 – Hinge Health had its price target raised by Stifel Nicolaus from $96.00 to $115.00. They now have a “buy” rating on the stock.
• 8/11/2026 – Hinge Health was downgraded by Zacks Research from “strong-buy” to “hold”.
• 8/10/2026 – Hinge Health had its price target raised by Truist Financial Corporation from $85.00 to $112.00. They now have a “buy” rating on the stock.

Insider Buying and Selling at Hinge Health

In other Hinge Health news, Director Kristina M. Leslie sold 1,200 shares of Hinge Health stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $88.23, for a total value of $105,876.00. Following the completion of the transaction, the director directly owned 30,387 shares in the company, valued at $2,681,045.01. The trade was a 3.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, President James Pursley sold 33,000 shares of the stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of $94.14, for a total value of $3,106,620.00. Following the sale, the president owned 666,909 shares in the company, valued at $62,782,813.26. The trade was a 4.71% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 776,861 shares of company stock worth $70,085,397. 18.92% of the stock is owned by insiders.

Hinge Health, Inc is a digital healthcare company focused on musculoskeletal (MSK) conditions, including back and joint pain. The company provides virtual care designed to help members manage pain, improve mobility and avoid or delay more invasive treatments.

Its platform combines a mobile application, motion-sensing technology, personalized exercise therapy, education and support from a care team that may include clinical specialists. Hinge Health offers programs for conditions such as chronic back pain, knee pain and other common MSK issues, with services generally provided through employers, health plans and other healthcare organizations.

Hinge Health was founded in 2015 and is headquartered in San Francisco, California.